Bartik MM - Search Results

1

Presence of an enlarged pool of MOPC-315-specific cytotoxic T lymphocyte precursors in the thymuses of mice that eradicated a large MOPC-315 tumor as a consequence of low-dose melphalan therapy.

Bartik MM, Ahn MC, Baumgartel BA, Hendricks RL, Mokyr MB. Bartik MM, et al. Cancer Immunol Immunother. 1990;32(3):143-53. doi: 10.1007/BF01771449. Cancer Immunol Immunother. 1990. PMID: 2289208 Free PMC article.

2

Enhanced expansion of the thymic CD8+ cell subset as a potential mechanism for the generation of enhanced antitumor cytotoxicity by thymocytes from low-dose melphalan-treated MOPC-315 tumor bearers.

Bartik MM, Baumgartel-Scofield BA, Mokyr MB. Bartik MM, et al. Cancer Immunol Immunother. 1991;34(2):79-89. doi: 10.1007/BF01741340. Cancer Immunol Immunother. 1991. PMID: 1760820 Free PMC article.

3

Interleukin 2 requirement for the in vitro generation of antitumor cytotoxicity by thymocytes from melphalan-cured MOPC-315 tumor bearers.

Mokyr MB, Bartik MM, Ahn MC. Mokyr MB, et al. Among authors: bartik mm. Cancer Res. 1989 Feb 15;49(4):870-6. Cancer Res. 1989. PMID: 2783557

4

Melphalan-induced appearance of potent antitumor immune reactivity in tumor bearer lymphocytes co-expressing the Lyt 2 and the L3T4 antigens.

Takesue BY, Bartik MM, Mokyr MB. Takesue BY, et al. Among authors: bartik mm. Int J Immunopharmacol. 1987;9(6):705-17. doi: 10.1016/0192-0561(87)90042-7. Int J Immunopharmacol. 1987. PMID: 2891627

5

Melphalan-induced enhancement of antitumor immune reactivity in thymocytes of adult BALB/c mice bearing a large MOPC-315 tumor.

Bartik MM, Takesue BY, Mokyr MB. Bartik MM, et al. Cancer Res. 1987 Sep 15;47(18):4848-55. Cancer Res. 1987. PMID: 3497711

6

Modulation of T cell proliferation by stimulation of the beta-adrenergic receptor: lack of correlation between inhibition of T cell proliferation and cAMP accumulation.

Bartik MM, Brooks WH, Roszman TL. Bartik MM, et al. Cell Immunol. 1993 May;148(2):408-21. doi: 10.1006/cimm.1993.1122. Cell Immunol. 1993. PMID: 8388322

7

Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells.

Bartik MM, Bauman GP, Brooks WH, Roszman TL. Bartik MM, et al. Cell Immunol. 1994 Oct 1;158(1):116-30. doi: 10.1006/cimm.1994.1261. Cell Immunol. 1994. PMID: 8087859

8

Induction of cAMP-dependent protein kinase (PKA) activity in T cells after stimulation of the prostaglandin E2 or the beta-adrenergic receptors: relationship between PKA activity and inhibition of anti-CD3 monoclonal antibody-induced T cell proliferation.

Bauman GP, Bartik MM, Brooks WH, Roszman TL. Bauman GP, et al. Among authors: bartik mm. Cell Immunol. 1994 Oct 1;158(1):182-94. doi: 10.1006/cimm.1994.1266. Cell Immunol. 1994. PMID: 8087864

9

cAMP accumulation in T-cells inhibits anti-CD3 monoclonal antibody-induced actin polymerization.

Selliah N, Bartik MM, Carlson SL, Brooks WH, Roszman TL. Selliah N, et al. Among authors: bartik mm. J Neuroimmunol. 1995 Jan;56(1):107-12. doi: 10.1016/0165-5728(94)00142-b. J Neuroimmunol. 1995. PMID: 7822476

10

Activation of human peripheral blood T cells does not lead to increased P-glycoprotein expression.

Mu XY, Gosland MP, Bartik MM, Schimmelpfennig J, Kay NE. Mu XY, et al. Among authors: bartik mm. J Clin Immunol. 1999 Jul;19(4):239-46. doi: 10.1023/a:1020572114862. J Clin Immunol. 1999. PMID: 10471978

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters